RA PHARMACEUTICALS INC's ticker is RARX and the CUSIP is 74933V108.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $233,245,000 | +2.3% | 4,858,260 | 0.0% | 7.37% | +6.6% |
| Q4 2019 | $227,998,000 | +98.4% | 4,858,260 | 0.0% | 6.91% | +1.0% |
| Q3 2019 | $114,898,000 | -16.1% | 4,858,260 | 0.0% | 6.85% | -6.9% |
| Q2 2019 | $136,959,000 | +25.9% | 4,858,260 | 0.0% | 7.35% | +56.7% |
| Q1 2019 | $108,825,000 | +220.4% | 4,858,260 | 0.0% | 4.69% | +137.4% |
| Q4 2018 | $33,963,000 | -51.3% | 4,858,260 | +26.1% | 1.98% | -46.9% |
| Q3 2018 | $69,679,000 | +81.8% | 3,851,808 | 0.0% | 3.72% | +49.7% |
| Q2 2018 | $38,325,000 | +87.4% | 3,851,808 | 0.0% | 2.49% | +58.8% |
| Q1 2018 | $20,453,000 | +78.0% | 3,851,808 | +184.9% | 1.57% | +63.1% |
| Q4 2017 | $11,490,000 | -41.8% | 1,351,808 | 0.0% | 0.96% | -46.1% |
| Q3 2017 | $19,736,000 | -22.1% | 1,351,808 | 0.0% | 1.78% | -38.7% |
| Q2 2017 | $25,333,000 | -12.0% | 1,351,808 | 0.0% | 2.91% | -17.6% |
| Q1 2017 | $28,780,000 | +40.2% | 1,351,808 | 0.0% | 3.53% | +21.3% |
| Q4 2016 | $20,534,000 | – | 1,351,808 | – | 2.91% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 6,138,797 | $145,183,000 | 12.02% |
| VHCP Management III, LLC | 670,350 | $15,854,000 | 9.79% |
| RA Capital Management | 4,858,260 | $114,898,000 | 6.85% |
| VHCP Management II, LLC | 677,164 | $16,015,000 | 6.10% |
| EMORY UNIVERSITY | 59,690 | $1,412,000 | 2.78% |
| SECTORAL ASSET MANAGEMENT INC | 451,247 | $10,672,000 | 1.84% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,728,019 | $40,868,000 | 1.67% |
| Opaleye Management Inc. | 141,800 | $3,354,000 | 1.21% |
| ACUTA CAPITAL PARTNERS, LLC | 55,000 | $1,301,000 | 0.94% |
| EAM Global Investors LLC | 69,035 | $1,633,000 | 0.80% |